US calls for pause on Johnson & Johnson vaccine after clotting cases
|In a statement published on Tuesday, the US Food and Drug Administration (FDA) recommended a pause in the use of Johnson & Johnson's coronavirus vaccine until they complete the review assessing blood clot cases in individuals, per Reuters.
"The FDA is reviewing data involving six reported US cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine," Reuters reported. "As of April 12, more than 6.8 million doses of Johnson & Johnson vaccine have been administered in the US."
Market reaction
This headline seems to be weighing on market sentiment. As of writing, the S&P 500 Futures were down nearly 0.3% on the day at 4,109.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.